Response to atomoxetine in boys with high‐functioning autism spectrum disorders and attention deficit/hyperactivity disorder

Abstract

Seven out of 14 boys with high-functioning ASD and comorbid AD/HD showed significant reductions in AD/HD symptoms and were classified as responders to atomoxetine. Most children tolerated the drug well.